• Target

    £500,000

  • Trackers

    12

  • Close Date

    Feb 24 2017

  • Status

    Live

RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to sell shares; the loss of the value of investment; and dilution of shareholding. When you invest any loss in value will not be covered by the the Financial Services Compensation Scheme. Please read FULL risk warning.

Orthogem Limited

Orthogem has developed a med device to access the spine fusion market and is seeking funding to realise this opportunity

Orthogem logo final rgb

Investment closes only once the total pledged amount passes the minimum of £250,000

Total Pledged: £612,784
Max

£500,000

This Pledge is not a commitment. You will be asked to confirm in the next section.

Track
Contact
Duedil
Twitter

Overview

Orthogem is an established UK manufacturer of Synthetic Bone Graft (SGB), TriPore, presented as granules. SBG's are used to help repair bone and are most often used alongside orthopaedic implants. SGB's reduce the need to harvest bone from a donor site on the patient, reducing the need for additional surgical incisions and the associated increased time in the operating theatre, potential site infections and post operative pain. Following the successful development of a putty formulation which is essential to compete in the Spine market (Over 50% of all bone grafting, c.$1bn, is conducted in Spine surgery), the company is now seeking £500k. This is to enable regulatory approval in the EU and US and to market and promote the product. Orthogem has an established distributor network with others lined up to promote TriPore putty at launch. Orthogem is led by a team with proven experience required to deliver significant success in this market.

This section is currently locked.
Please Sign Up or Log In to unlock.

Discussions

This section is currently locked.
Please Sign Up or Log In to unlock.

Deal documents

This section is currently locked.
Please Sign Up or Log In to unlock.